SCHEDULE 13G/A

RAPT Therapeutics Inc

Common Stock, $0.0001 par value per share · CUSIP: 75382E208

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Redmile Group, LLC

  Shares: 1,765,303.00 · Class: 9.9%

• Jeremy C. Green

  Shares: 1,765,303.00 · Class: 9.9%

• Redmile Biopharma Investments III, L.P.

  Shares: 1,147,390.00 · Class: 6.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.